 CAMBRIDGE, Mass., March 08, 2022 GLOBE NEWSWIRE -- Beam Therapeutics Inc. Nasdaq: BEAM, a biotechnology company developing precision genetic medicines through base editing, today announced that Giuseppe Ciaramella, Ph.D., president and chief scientific officer, will participate in a fireside chat during the Barclays 2022 Global Healthcare Conference on Tuesday, March 15, 2022 at 8:30 a.m. ET. The conference will be held in Miami, FL from March 15-17, 2022. 